Award
NIH Reporter #1R01CA316459-01
Developing combination treatment strategies for pancreatic cancer
Recipient
University of Pennsylvania
Award Amount
$523,313.00
Ceiling
$523,313.00
Awarded
August 10, 2026
Identifier
1R01CA316459-01
NIH grant awarded to University of Pennsylvania for research on combination treatment strategies targeting pancreatic cancer, focusing on KRAS inhibitor resistance and novel therapeutic approaches.
Description
This NIH grant supports research on developing combination therapies for pancreatic cancer, focusing on overcoming resistance mechanisms related to KRAS and other genetic alterations. The project involves computational and functional biology approaches, mouse models, and aims to identify novel drug targets and therapeutic strategies.